Scientists have been able to find new treatments for the most severe form of skin cancer after a major scientific breakthrough.
Scientists have discovered that inhibiting a key metabolic enzyme “shows promise” in tackling melanoma, which is one of the most common cancers worldwide. For the first time, scientists at Sanford Burnham Prebys in California have demonstrated that inhibiting the enzyme kills melanoma cells specifically and prevents tumor growth. The study’s results, which were published in the journal Nature Cell Biology, suggest that they may help develop a new class of medications that target melanoma specifically. Dr. Verma said “In the study, we used genetic techniques to inhibit GCDH (Glutaryl-CoA Dehydrogenase), which provides the proof of concept to seek for small chemical inhibitors,” she continued: ” In fact, we are actively looking for possible GCDH-inhibiting medications that could be used as cutting-edge melanoma treatments.”